The Discounted Cash Flow (DCF) valuation of Puma Biotechnology Inc (PBYI) is 7.82 USD. With the latest stock price at 2.88 USD, the upside of Puma Biotechnology Inc based on DCF is 171.6%.
| Range | Selected | |
| WACC / Discount Rate | 7.5% - 10.8% | 9.2% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 6.32 - 10.32 | 7.82 |
| Upside | 119.6% - 258.3% | 171.6% |